Probiotics may reduce incidence of acute respiratory infections

A recent study sponsored by Chr. Hansen has determined that if certain strains of probiotics were administered to the U.S. public, healthcare costs related to respiratory infections would decrease by up to $1.4 billion.

Cargill–DSM joint venture Avansya starts commercial-scale production of EverSweet

Avansya, the joint venture between Cargill and Royal DSM, has started production at the first commercial-scale fermentation facility for stevia sweeteners in the United States.